Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded siRNA oligonucleotide directed against the keratin 6a N171K mutation

EU orphan designation number: EU/3/13/1141   
Active ingredient: Synthetic double-stranded siRNA oligonucleotide directed against the keratin 6a N171K mutation
Indication: Treatment of pachyonychia congenita
Sponsor: Alan Irvine
Professor of Dermatology, Our Lady's Children's Hospital Crumlin, Dublin 12, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/06/2013 Orphan designation EMA/OD/028/13 (2013)3962 of 19/06/2013
01/10/2013 Corrigendum (2013)6434 of 27/09/2013